Trials / NCT01864486
Restoring Vision With the Intelligent Retinal Implant System (IRIS V1)in Patients With Retinal Dystrophy
Completed N/A Retinal implant
- Sponsor
- Science Corporation
- Treatment
- Intelligent Retinal Implant System
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa, Cone Rod Dystrophy, Choroideremia
- Ages
- 25 Years to no upper limit
- Enrollment
- 20 participants
- Started
- 2013-04
- Main results expected
- 2017-10-13
- Results posted
- Not yet
- Record last updated
- 2017-10-17
What the study is testing
This study evaluates the safety and effectiveness of the Intelligent Retinal Implants System (IRIS V1)
Where it runs
Austria (1)
- Medical University of Graz, Graz
France (2)
- Clinique Ophtalmologique du CHU de Nantes, Nantes
- Hopital des Quinze Vingts/Fondation Ophtalmologique A. De Rothschild, Paris
Germany (2)
- Dept. of Ophthalmology, University of Bonn, Bonn
- Klinik und Poliklinik für Augenheilkunde Hamburg-Eppendorf, Hamburg